Kestra Medical Technologies, Ltd. Common Stock Cash Flow-to-Debt Ratio
Kestra Medical Technologies, Ltd. Common Stock cash flow-to-debt ratio. Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a Cash Flow-to-Debt Ratio of -0.20x as of January 2026, meaning its operating cash flow of $-18.37 Million could theoretically repay 0% of its total liabilities ($91.35 Million) in one year. See financial agility of Kestra Medical Technologies, Ltd. Common to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
Cash flow-to-debt ratio of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. Historical debt coverage capacity for Kestra Medical Technologies, Ltd. Common Stock across 5 annual periods. Also explore KMTS net assets growth trend to track the company's year-over-year net asset growth rate.
Kestra Medical Technologies, Ltd. Common Stock Cash Flow-to-Debt Ratio by Year (2020–2025)
Kestra Medical Technologies, Ltd. Common Stock cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Kestra Medical Technologies, Ltd. Common Stock. For the full cash flow conversion analysis, see cash flow conversion of Kestra Medical Technologies, Ltd. Common.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.86x | $-77.61 Million | $90.34 Million | ▼ -203.7% |
| 2024 | -0.28x | $-72.23 Million | $255.33 Million | ▲ +36.5% |
| 2023 | -0.45x | $-69.64 Million | $156.23 Million | ▲ +57.1% |
| 2021 | -1.04x | $-29.89 Million | $28.76 Million | ▲ +86.2% |
| 2020 | -7.54x | $-30.29 Million | $4.02 Million | — |